Tower Research Capital LLC (Trc) Candel Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,736 shares of CADL stock, worth $11,655. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,736
Previous 1,252
118.53%
Holding current value
$11,655
Previous $7,000
157.14%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CADL
# of Institutions
57Shares Held
6.43MCall Options Held
109KPut Options Held
130K-
Northpond Ventures, LLC1.94MShares$8.24 Million48.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA946KShares$4.03 Million0.0% of portfolio
-
Black Rock Inc. New York, NY823KShares$3.51 Million0.0% of portfolio
-
State Street Corp Boston, MA492KShares$2.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA449KShares$1.91 Million0.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $123M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...